News

The American Journal of Managed Care13h
C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma
The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.
The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its ...